Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: - squamous cell carcinoma: skin, larynx and paralarynx, penis, cervix and vulva. lung cancer and cervical carcinoma. lymphomas: hodgkin's lymphoma (no longer treatable by bone marrow depressant agents) and non-hodgkin's lymphoma including reticulum cell sarcoma and lymphosarcoma. testicular carcinoma: embryonal cell carcinoma, choriocarcinoma, and teratocarcimona. pleurodysis and pleural fluid accumulation. renal carcinomas and soft tissue sarcomas.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - bleomycin sulfate, quantity: 15000 iu - injection, powder for - excipient ingredients: - squamous cell carcinoma affecting the mouth, nasopharynx, larynx, paranasal sinuses, oesophagus, external genitalia, cervix or skin. hodgkin's disease and other malignant lymphomas including mycosis fungoides. testicular teratoma. malignant effusions of the serous cavities. metastatic melanoma and the carcinomas of the thyroid, lung and bladder.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - bleomycin sulfate, quantity: 30 iu - injection, powder for - excipient ingredients: sulfuric acid; sodium hydroxide - bleomycin injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other chemotherapeutic agents. squamous cell carcinoma, lymphomas and testicular carcinomas.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

leo pharma limited - sodium fusidate 250mg; sodium fusidate 250mg - film coated tablet - 250 mg - active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone gelatin hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc titanium dioxide active: sodium fusidate 250mg excipient: colloidal silicon dioxide crospovidone dl-alpha tocopheryl acetate hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose purified talc titanium dioxide - treatment of localised as well as generalised staphylococcal infections (e.g. abscesses, furunculosis, wound infections, pneumonia, peritonitis, osteomyelitis, septicaemia, enteritis and otorhinolaryngeal infections).

Singapore - engelsk - HSA (Health Sciences Authority)

leo pharma asia pte ltd - alfacalcidol - solution - 2 mcg/ml - alfacalcidol 2 mcg/ml

Singapore - engelsk - HSA (Health Sciences Authority)

leo pharma asia pte ltd - protamine sulphate - injection - 10 mg/ml

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

kyowa kirin ltd - bleomycin sulfate - powder for solution for injection - 15000unit

Irland - engelsk - HPRA (Health Products Regulatory Authority)

roche products (ireland) ltd - valganciclovir - film-coated tablet - 450 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valganciclovir

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hospira malaysia sdn bhd - bleomycin sulphate -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

healol pharmaceuticals sdn. bhd. - clopidogrel bisulphate -